Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Graphic explaining MVAC process

A Final MVAC Blueprint—and the Start of an R&D Revolution?

Despite decades of investment, TB remains a global crisis. Each year, TB kills 1.6 million people—making it the world’s deadliest infectious diseases. We have set out to develop a solution: what we ultimately called the Market-Driven, Value-Based Advance Commitment (MVAC), a mechanism to create and guarantee a market for better TB treatment, if and when such a treatment becomes available.

Vaccines for Gavi

Gavi, The Vaccine Alliance: Doubling Down on Coverage, Partnerships, and Transition Incentives for the Next Phase

With the Global Fund and Global Polio Eradication Initiative replenishments successfully concluded, donors are turning their attention to the Gavi Alliance whose third replenishment process is scheduled to culminate in summer 2020. As the final Gavi Board meeting of 2019 kicks off next week, it’s time to sharpen goals and double down on strategies to enhance the partnership’s public health impact.

A nurse at Merawi health centre in northern Ethiopia prepares a measles vaccine for delivery.

We Asked, You Answered: Reflections on the First Round of MVAC Feedback

In March, our team at the Center for Global Development and Office of Health Economics posted a consultation draft of a policy proposal for a Market-Driven, Value-Based Advanced Commitment (MVAC). The MVAC is a new mechanism that puts middle-income country governments in the driver’s seat to accelerate R&D for diseases that affect the world’s poor—specifically, the 10 million men, women, and children who develop tuberculosis (TB) disease each year and desperately need better therapies. 

A child receives the oral Polio vaccine at a clinic in Freetown, Sierra Leone. Photo by Dominic Chavez/World Bank

Gavi@20: What’s Next for Global Immunization Efforts

The Board of Gavi, The Vaccine Alliance, will retreat next week to discuss a new strategy and replenishment. My colleagues and I have put together a preliminary set of six short notes that examine different dimensions of Gavi’s work and make recommendations for ways to address identified issues.

Child receives immunization in Uttar Pradesh

Gavi Going Forward: Immunization for Every Child Everywhere?

In December 2018, the Gavi Alliance hosted a mid-term review to assess progress towards its core purpose: “reach every child everywhere with vaccines against preventable diseases.” The good news is that there’s been advances on new vaccine introductions, and an estimated 65 million children were immunized with Gavi-supported new and underutilized vaccines in 2017. The bad news? There is still huge variability on the measure that counts most for building herd immunity and reducing vaccine-preventable disease: full vaccination for age among children under 2 years old.

Pages